Skip to main content
Clinical Trials/NCT06437743
NCT06437743
Not yet recruiting
Not Applicable

Monitoring Nociception Using NoL Index and Its Implications in Reducing Opioid-Related Complications in Laparoscopic Abdominal Surgery

Investigation Group Anesthesia, Resuscitation, And Perioperative Medicine of Aragon0 sites282 target enrollmentJune 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Postoperative Opioid-related Complications
Sponsor
Investigation Group Anesthesia, Resuscitation, And Perioperative Medicine of Aragon
Enrollment
282
Primary Endpoint
Reduction in Postoperative Opioid-Related Complications
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

This study aims to determine if optimal intraoperative nociception monitoring using the NoL index can reduce postoperative complications related to opioid use in laparoscopic abdominal surgery. The hypothesis is that guided nociception monitoring decreases opioid-related complications and improves postoperative outcomes.

Detailed Description

The study is a prospective, observational cohort study conducted across multiple centers. It aims to evaluate the impact of intraoperative nociception monitoring on postoperative opioid-related complications. The study will involve two groups of patients undergoing laparoscopic abdominal surgery: one group with visible NoL monitoring and another with non-visible NoL monitoring.

Registry
clinicaltrials.gov
Start Date
June 1, 2024
End Date
June 1, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Investigation Group Anesthesia, Resuscitation, And Perioperative Medicine of Aragon
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years
  • Scheduled for laparoscopic abdominal surgery
  • Undergoing balanced general anesthesia
  • ASA physical status I-III
  • Signed informed consent

Exclusion Criteria

  • Refusal to participate
  • Communication barriers
  • Multimodal, opioid-free, or regional epidural anesthesia
  • ASA IV or V
  • Pregnant or breastfeeding women
  • Open or emergency abdominal surgery
  • Post-surgery transfer to ICU or Recovery Unit

Outcomes

Primary Outcomes

Reduction in Postoperative Opioid-Related Complications

Time Frame: From the end of surgery up to 48 hours postoperatively

The primary outcome measure will evaluate the incidence of postoperative opioid-related complications in patients undergoing laparoscopic abdominal surgery. Complications include nausea, vomiting, respiratory depression, and opioid-induced hyperalgesia. The study aims to determine if the use of the NoL monitor to guide intraoperative analgesia reduces these complications compared to standard hemodynamic monitoring.

Secondary Outcomes

  • Postoperative Pain Scores(At 1, 6, 12, 24, and 48 hours postoperatively)
  • Length of Hospital Stay(From admission to discharge, up to 7 days postoperatively)
  • Intraoperative Opioid Consumption(During the surgical procedure)

Similar Trials